Hybrid spheroids containing mesenchymal stem cells promote therapeutic angiogenesis by increasing engraftment of co-transplanted endothelial colony-forming cells in vivo.
Young Cheol SongGyu Tae ParkHye Ji MoonEun-Bae ChoiMi-Ju LimJung Won YoonNayeon LeeSang Mo KwonByung-Joo LeeJae-Ho KimPublished in: Stem cell research & therapy (2023)
These results suggest that hybrid spheroids containing MSCs can serve as carriers for cell transplantation of ECFCs which have poor in vivo engraftment efficiency.